Quantcast

Latest The Wellcome Trust Stories

2014-10-09 12:29:10

- $5.8 million award will help advance the development of oxygen-carrying therapeutics for cancer - SAN CARLOS, Calif., Oct. 9, 2014 /PRNewswire/ -- Omniox, Inc., an IND-stage biopharmaceutical company developing therapeutics for hypoxic diseases, announced today that the company has been granted a Translation Fund Award from the Wellcome Trust. The $5.8 million award will advance development of Omniox's lead product, OMX-4.80, for the treatment of hypoxic cancers including...

2014-05-16 08:25:52

CAMBRIDGE, England, May 16, 2014 /PRNewswire/ -- Series B Financing includes the Wellcome Trust and the Bill & Melinda Gates Foundation Kymab, a monoclonal antibody biopharmaceutical company, announced today it has successfully raised US$40 million in a Series B financing. The Bill & Melinda Gates Foundation joins existing investor, the Wellcome Trust, each investing US$20 million. The funds will enable Kymab to maximise the potential of its Kymouse(TM)...

Lonely Bacteria Increase Risk Of Resistance To Antibiotics
2014-04-30 03:29:48

Wellcome Trust Scientists from The University of Manchester have discovered that 'lonely' microbes are more likely to mutate, resulting in higher rates of antibiotic resistance. The study, published today in Nature Communications and jointly funded by The Wellcome Trust and Engineering and Physical Sciences Research Council, explored the mutation rates of E. coli. Researchers found out that the rate of mutation varied according to how many of the bacteria there were. Surprisingly,...

2014-03-16 16:20:46

CAMBRIDGE, England, March 16, 2014 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company founded on research from the Wellcome Trust Sanger Institute, announced today the publication in Nature Biotechnology of a paper describing its breakthrough therapeutic antibody discovery technology, Kymouse(TM) (http://dx.doi.org). Scientists at Kymab have engineered a mouse with the full set of genes encoding the human antibody repertoire, calling this...

Breakthrough In The Battle Against Malaria
2011-11-30 05:54:45

Study identifies new ways to kill the human malaria parasite, Plasmodium falciparum An international team of scientists has announced a breakthrough in the fight against malaria, paving the way for the development of new drugs to treat the deadly disease. According to the World Health Organisation malaria currently infects more than 225 million people worldwide and accounts for nearly 800,000 deaths per year. Most deaths occur among children living in Africa where a child dies every 45...

2010-06-07 07:00:00

SOUTH PLAINFIELD, N.J., June 7 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the receipt of a $5.4 million Seeding Drug Discovery (SDD) Award from The Wellcome Trust to support the development of drugs that target Bmi-1, a protein that has been linked to drug resistant cancers. Bmi-1 has been implicated in a wide variety of cancers and has been demonstrated to contribute to drug resistance and treatment failure. It acts by switching off regulatory pathways inside the cell...

b9be4a9289e368822f36d0b68442b1ee
2009-12-01 07:35:00

Deadly bug targets vulnerable children and adults in Africa Researchers have characterized a new multi drug resistant strain of Salmonella Typhimurium that is causing life-threatening disease in Africa. This type of Salmonella bug normally causes diarrhea and is rarely fatal. The new strain infects vulnerable children and adults in many regions of sub-Saharan Africa leading to death in up to one in four cases. The new genome work, a collaboration between the Wellcome Trust Sanger Institute,...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related